148 related articles for article (PubMed ID: 38206901)
1. User-experience testing of an evidence-to-decision framework for selecting essential medicines.
Piggott T; Moja L; Garcia CAC; Akl EA; Banzi R; Huttner B; Kredo T; Lavis JN; Schünemann HJ
PLOS Glob Public Health; 2024; 4(1):e0002723. PubMed ID: 38206901
[TBL] [Abstract][Full Text] [Related]
2. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
Piggott T; Moja L; Jenei K; Kredo T; Skoetz N; Banzi R; Trapani D; Leong T; McCaul M; Lavis JN; Akl EA; Nonino F; Iorio A; Laurson-Doube J; Huttner BD; Schünemann HJ
J Clin Epidemiol; 2024 Feb; 166():111241. PubMed ID: 38123105
[TBL] [Abstract][Full Text] [Related]
3. Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study.
Piggott T; Moja L; Akl EA; Lavis JN; Cooke G; Kredo T; Hogerzeil HV; Huttner B; Alonso-Coello P; Schünemann H
J Clin Epidemiol; 2023 Feb; 154():146-155. PubMed ID: 36584732
[TBL] [Abstract][Full Text] [Related]
4. Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jan; 17(1):17. PubMed ID: 28061899
[TBL] [Abstract][Full Text] [Related]
5. Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.
Roitberg F; Amaral T; Cherny NI; Giuliani R; Latino NJ; Galotti M; Bricalli G; Curigliano G; Pentheroudakis G; Trapani D
ESMO Open; 2023 Oct; 8(5):101617. PubMed ID: 37672862
[TBL] [Abstract][Full Text] [Related]
6. National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis.
Peacocke EF; Myhre SL; Foss HS; Gopinathan U
PLoS Med; 2022 Mar; 19(3):e1003944. PubMed ID: 35275938
[TBL] [Abstract][Full Text] [Related]
7. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
8. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
[TBL] [Abstract][Full Text] [Related]
9. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
[TBL] [Abstract][Full Text] [Related]
10. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis LA; Calvello Hynes EJ
Afr J Emerg Med; 2018 Sep; 8(3):110-117. PubMed ID: 30456159
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of essential medicines lists: the South African case study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
[TBL] [Abstract][Full Text] [Related]
12. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM; Beall R; Yang J; Mackey TK
Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
[TBL] [Abstract][Full Text] [Related]
13. Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders.
Papola D; Ostuzzi G; Todesco B; Gastaldon C; Hanna F; Chatterjee S; van Ommeren M; Barbui C
Lancet Psychiatry; 2023 Oct; 10(10):809-816. PubMed ID: 37475123
[TBL] [Abstract][Full Text] [Related]
14. Burden of alcohol use and inclusion of alcohol use disorder medications in the essential medicine lists across 132 countries: An observational study.
Parmar A; Sahu DP; Behera P
Alcohol; 2024 Feb; ():. PubMed ID: 38423262
[TBL] [Abstract][Full Text] [Related]
15. [GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health].
Morche J; Conrad S; Passon A; Perleth M; Gartlehner G; Meerpohl JJ; Schünemann HJ
Z Evid Fortbild Qual Gesundhwes; 2018 May; 133():58-66. PubMed ID: 29673801
[TBL] [Abstract][Full Text] [Related]
16. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health.
Schünemann HJ; Mustafa R; Brozek J; Santesso N; Alonso-Coello P; Guyatt G; Scholten R; Langendam M; Leeflang MM; Akl EA; Singh JA; Meerpohl J; Hultcrantz M; Bossuyt P; Oxman AD;
J Clin Epidemiol; 2016 Aug; 76():89-98. PubMed ID: 26931285
[TBL] [Abstract][Full Text] [Related]
17. 25 years of the WHO essential medicines lists: progress and challenges.
Laing R; Waning B; Gray A; Ford N; 't Hoen E
Lancet; 2003 May; 361(9370):1723-9. PubMed ID: 12767751
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
[TBL] [Abstract][Full Text] [Related]
20. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus.
Babatunde D; Pollock AM; Ocan M; Brhlikova P
JRSM Open; 2024 Mar; 15(3):20542704241232814. PubMed ID: 38560365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
